Thymulin
preclinicalAlso known as: FTS, Facteur Thymique Serique
**Mechanism of Action** Thymulin (Facteur Thymique Serique, FTS) is a zinc-dependent nonapeptide secreted by thymic epithelial cells. Its biological activity requires chelation of zinc ions, which stabilizes its conformation for binding to high-affinity receptors on T-cell precursors and mature lymphocytes. Thymulin promotes T-cell differentiation, maturation, and functional modulation, including enhancement of cytotoxic T-cell activity and regulation of cytokine production (e.g., IL-2, IFN-γ). Additionally, it exerts analgesic effects via opioid receptor pathways and anti-inflammatory actions through suppression of pro-inflammatory mediators such as TNF-α and IL-1β. **Key Research Findings** Preclinical studies demonstrate thymulin’s immunomodulatory capacity in models of immunodeficiency, autoimmunity, and infection. In aged or thymectomized animals, exogenous thymulin restores T-cell numbers and function. Its analgesic properties have been shown in rodent pain models, with effects comparable to morphine but without tolerance development. Anti-inflammatory effects are observed in models of arthritis and sepsis, where thymulin reduces edema and inflammatory cytokine levels. However, its short half-life and zinc-dependent stability limit translational progress. **Clinical Relevance** Thymulin remains in preclinical development, with no approved human applications. Potential therapeutic areas include immune reconstitution in aging or HIV, autoimmune disease modulation, and chronic pain management. Challenges include optimizing delivery systems (e.g., zinc-stabilized formulations) and establishing safety profiles. Current evidence supports further investigation but does not justify clinical use. For research purposes only — not medical advice.
Key data
C33H54N12O15Research & studies
Thymic peptide hormones (thymosin, thymulin, thymopoietin) circulate to impact peripheral immune cells and tumor biology.; Intrathymic T cell differentiation is regulated by stromal cell-derived hormones and cytokines.; Manipulating the thymic microenvironment may improve cancer treatment responses and reduce adverse effects.; Evidence from clinical and preclinical studies shows complex immunoendocrine interactions in anti-tumor immunity.
Thymic peptides have two known categories of effects: influence on immune cells and interconnection with neuroendocrine systems.; A third, previously unclear aspect involves intranuclear precursors of thymic peptides that are ubiquitous and highly abundant in all somatic cells.; Under stress-related conditions, these precursors are cleaved to form immunologically active peptides that leave the nucleus and intracellular spaces.; These peptides act as 'distress signals' to the immune system, functioning as stress sensors and potentially linking somatic cells to immune and neuroendocrine systems.
Thymulin production and secretion are strongly influenced by the neuroendocrine system.; Thymulin and its synthetic analog exhibit anti-inflammatory and analgesic effects in the central nervous system and other organs.; Gene therapy with a bidirectional Tet-Off vector expressing metFTS can prevent hormonal and reproductive abnormalities in congenitally athymic mice.; Novel biotechnological tools may enable restoration of circulating thymulin levels in thymodeficient models and potentially humans.
Adenoviral vector with synthetic thymulin gene restored normal thymulin levels for months in thymectomized and nude mice/rats.; Thymulin gene therapy in nude mice prevented post-pubertal pituitary and ovarian alterations.; Neonatal thymulin gene therapy prevented lipid metabolism abnormalities in congenitally athymic mice.; Adenovirally-delivered thymulin showed longer brain expression than reporter genes, consistent with its antiinflammatory activity.
Thymulin is a nonapeptide coupled to zinc, which is essential for its biological activity.; Thymulin production and secretion are strongly regulated by the neuroendocrine system.; Thymulin acts as a hypophysotropic peptide, influencing pituitary function.; The peptide is a key component of the hypophyso-thymic axis.
Frequently asked questions
What is Thymulin?
**Mechanism of Action** Thymulin (Facteur Thymique Serique, FTS) is a zinc-dependent nonapeptide secreted by thymic epithelial cells. Its biological activity requires chelation of zinc ions, which stabilizes its conformation for binding to high-affinity receptors on T-cell precursors and mature lymphocytes. Thymulin pr
How does Thymulin work?
Zinc-dependent thymic nonapeptide that regulates T-cell differentiation and has analgesic and anti-inflammatory effects.
What is the research status of Thymulin?
Thymulin is currently classified as preclinical, with 374 research references on record. This is for research purposes only and is not medical advice.
What is the molecular weight of Thymulin?
Thymulin has a molecular weight of approximately 858.9 g/mol (formula C33H54N12O15).
Related peptides
Human cathelicidin antimicrobial peptide with broad-spectrum antibacterial, immunomodulatory, and wound-healing activity.
28-aa thymic peptide that enhances T-cell maturation and TLR signaling; approved in many countries for hepatitis and as an immune adjuvant.
Synthetic dipeptide (Glu-Trp) immunomodulator used in Eastern Europe to restore immune balance during infection and immunodeficiency.
Build on Thymulin data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key